Skip to main content
HR 3758 108th Congress House Health Access to health care Child health Commerce Communication in medicine Drug industry Drugs Education Electronic government information Epidemics Epidemiology Families Federal-state relations Government Operations and Politics Government paperwork Government publicity Health education Health planning Higher education Income tax

Flu Protection Act of 2004

Introduced: February 3, 2004 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 24, 2004
Referred to the Subcommittee on Health.
Feb 3, 2004
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 3, 2004
Introduced in House
Feb 3, 2004
Sponsor introductory remarks on measure. (CR E105)
 Plain-English summary Congressional Research Service

Flu Protection Act of 2004 - Amends the Public Health Act to require: (1) the Secretary of Health and Human Services, through the Director of the Centers for Disease Control and Prevention, to conduct annual public influenza awareness campaign and education and outreach (including Medicare outreach) efforts preceding the flu season; (2) the Director to contract with influenza vaccine manufacturers to ensure the availability of additional doses of flu vaccine; (3) the Director to encourage States to develop a contingency immunization plan for high-risk populations in the event of a vaccine delay or shortage; and (4) the Secretary, through the Director, to establish a protocol to attempt to prevent, prepare for, and respond to an influenza epidemic or pandemic.

Requires a manufacturer of a vaccine that receives Federal authority to distribute such vaccine to provide the Department of Health and Human Services (HHS) with advance notice of such manufacturer's intent to stop marketplace distribution of the vaccine.

Amends the Internal Revenue Code to: (1) establish a vaccine manufacturing facilities investment tax credit (20 percent of qualifying property per year) for property placed in service by December 31, 2008; and (2) define "vaccine manufacturing facilities property."

What's happening now February 24, 2004

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3
 Cosponsors 5
All 5 Democratic 5